Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. (Q51366605)
Jump to navigation
Jump to search
scientific article published on 20 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. |
scientific article published on 20 October 2011 |
Statements
1 reference
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. (English)
1 reference
Stefano Del Prato
1 reference
Antonio Nicolucci
1 reference
Augusto C Lovagnini-Scher
1 reference
Salvatore Turco
1 reference
Sergio Leotta
1 reference
Giacomo Vespasiani
1 reference
ELEONOR Study Group
1 reference
20 October 2011
1 reference
14
1 reference
2
1 reference
175-182
1 reference
Identifiers
1 reference